Global perspective Human stories
…
continue reading
Content provided by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Rescheduling Cannabis and SAFER Banking: More Substance Than Show?
MP3•Episode home
Manage episode 379535785 series 1389458
Content provided by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
When Biden announced moves last year to reform cannabis, most thought it was just virtue signaling. Then, late last month, the Department of Health and Human Services surprised the entire industry with a recommendation to reclassify cannabis from Schedule 1 to Schedule 3 under the Controlled Substances Act. A few weeks later, the Congressional Research Service predicted the DEA would follow that recommendation “if past is prologue." And most recently, a perennially debated bipartisan bill that would open up banking options to the cannabis industry passed a key Senate committee for the first time. How long will the DEA process take? Will they follow HHS’s recommendation or go for a middle-of-the-road option? Will the SAFER Banking Act survive further votes in the full Senate and Republican-controlled House? How will this impact the nation’s $33 billion cannabis industry? Tune in as shareholder Joshua Weiss and policy advisor Osiris Morel discuss recent developments and predict where we go from here.
…
continue reading
223 episodes
MP3•Episode home
Manage episode 379535785 series 1389458
Content provided by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Brownstein Podcast Series and Brownstein Hyatt Farber Schreck or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
When Biden announced moves last year to reform cannabis, most thought it was just virtue signaling. Then, late last month, the Department of Health and Human Services surprised the entire industry with a recommendation to reclassify cannabis from Schedule 1 to Schedule 3 under the Controlled Substances Act. A few weeks later, the Congressional Research Service predicted the DEA would follow that recommendation “if past is prologue." And most recently, a perennially debated bipartisan bill that would open up banking options to the cannabis industry passed a key Senate committee for the first time. How long will the DEA process take? Will they follow HHS’s recommendation or go for a middle-of-the-road option? Will the SAFER Banking Act survive further votes in the full Senate and Republican-controlled House? How will this impact the nation’s $33 billion cannabis industry? Tune in as shareholder Joshua Weiss and policy advisor Osiris Morel discuss recent developments and predict where we go from here.
…
continue reading
223 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.